We are live on ! Find out more
PC

Pier Capital Portfolio holdings

AUM $755M
1-Year Est. Return 94.38%
This Fund
S&P 500
This Quarter Est. Return
+18.25%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$699M
AUM Growth
+$78.9M
Cap. Flow
-$3.1M
Cap. Flow %
-0.44%
Top 10 Hldgs %
17.4%
Holding
139
New
21
Increased
40
Reduced
54
Closed
22

Top Buys

Rank Stock Value
1
GSHD icon
Goosehead Insurance
GSHD
+$9.31M
2
PNFP icon
Pinnacle Financial Partners Inc
PNFP
+$7.26M
3
BLD
TopBuild
BLD
+$6.92M
4
SFM icon
Sprouts Farmers Market
SFM
+$6.05M
5
CCS icon
Century Communities
CCS
+$5.24M

Top Sells

Rank Stock Value
1
AMED
Amedisys
AMED
+$9.07M
2
FCN icon
FTI Consulting
FCN
+$8.27M
3
CXM icon
Sprinklr
CXM
+$7.73M
4
SHLS icon
Shoals Technologies Group
SHLS
+$6.76M
5
PZZA icon
Papa John's
PZZA
+$6.76M

Sector Composition

Rank Sector Weight
1 Technology 26.72%
2 Healthcare 21.49%
3 Industrials 18.54%
4 Consumer Discretionary 12.8%
5 Consumer Staples 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FND icon
76
Floor & Decor
FND
$6.32B
$4.36M 0.62%
39,126
-28,663
-42% -$2.64M
CFLT
77
DELISTED
Confluent
CFLT
$4.3M 0.62%
183,842
-2,003
-1% -$48.4K
STVN icon
78
Stevanato
STVN
$5.8B
$4.27M 0.61%
156,503
+136,503
+683% +$3.93M
SLAB icon
79
Silicon Laboratories
SLAB
$7.3B
$4.25M 0.61%
32,165
-11,080
-26% -$1.21M
BOOT icon
80
Boot Barn
BOOT
$4.87B
$4.23M 0.61%
+55,117
New +$4.14M
FCN icon
81
FTI Consulting
FCN
$4.24B
$4.2M 0.6%
21,066
-39,987
-65% -$8.27M
CRNX icon
82
Crinetics Pharmaceuticals
CRNX
$8.96B
$4.15M 0.59%
+116,603
New +$3.58M
ITCI
83
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.94M 0.56%
55,050
-94,079
-63% -$5.41M
WSC icon
84
WillScot Mobile Mini Holdings
WSC
$4.17B
$3.85M 0.55%
86,500
-85,861
-50% -$3.47M
SITE icon
85
SiteOne Landscape Supply
SITE
$4.22B
$3.83M 0.55%
23,540
-10,311
-30% -$1.5M
DAWN
86
DELISTED
Day One Biopharmaceuticals
DAWN
$3.78M 0.54%
+258,685
New +$3.14M
DNLI icon
87
Denali Therapeutics
DNLI
$4.04B
$3.74M 0.53%
174,219
+49,139
+39% +$973K
ROIV icon
88
Roivant Sciences
ROIV
$26.2B
$3.72M 0.53%
331,267
-3,736
-1% -$36.4K
ADPT icon
89
Adaptive Biotechnologies
ADPT
$3.89B
$3.48M 0.5%
711,107
-7,960
-1% -$36.3K
SG icon
90
Sweetgreen
SG
$693M
$2.87M 0.41%
+254,190
New +$2.67M
FUSN
91
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$2.66M 0.38%
+277,111
New +$1.35M
PRTA icon
92
Prothena Corp
PRTA
$475M
$2.07M 0.3%
56,829
-627
-1% -$24.1K
MRVI icon
93
Maravai LifeSciences
MRVI
$861M
$1.88M 0.27%
286,849
-3,714
-1% -$24K
GPCR icon
94
Structure Therapeutics
GPCR
$3.83B
$1.45M 0.21%
+35,653
New +$2.04M
MSCI icon
95
MSCI
MSCI
$40.9B
$1.24M 0.18%
2,188
+1,043
+91% +$538K
TW icon
96
Tradeweb Markets
TW
$21.9B
$909K 0.13%
9,998
+486
+5% +$43.4K
DXCM icon
97
DexCom
DXCM
$34.3B
$794K 0.11%
6,400
+1,728
+37% +$177K
MPWR icon
98
Monolithic Power Systems
MPWR
$67B
$754K 0.11%
1,195
+525
+78% +$274K
DT icon
99
Dynatrace
DT
$14.3B
$712K 0.1%
13,026
+12,623
+3,132% +$638K
LNG icon
100
Cheniere Energy
LNG
$55.4B
$662K 0.09%
3,875
+216
+6% +$37.1K
2 3
4
5 6

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MGM
Manchester Global Management London, United Kingdom $749M AUM 37.16% 1-Year Est. Return

Pier Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Pier Capital held 139 positions worth $699M, up 13% from $620M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Pier Capital's Q4 2023 filing shows 21 new, 40 increased, 54 reduced and 22 closed positions. Its largest new stake was Goosehead Insurance: 128,793 shares worth $9.76M. The largest sale was Amedisys, an estimated $9.07M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Pier Capital's largest Q4 2023 buy was Goosehead Insurance: 128,793 shares worth $9.76M.
  • Pier Capital added most to Stevanato in Q4 2023, an estimated $3.93M increase.
  • Pier Capital's biggest Q4 2023 reduction was FTI Consulting, cutting an estimated $8.27M.
  • Pier Capital fully exited Amedisys in Q4 2023, selling an estimated $9.07M.
  • Pier Capital's ten largest holdings make up 17% of its $699M portfolio in Q4 2023.
  • Pier Capital opened 21 new positions and closed 22 in Q4 2023.
  • Pier Capital's portfolio value rose 13% quarter-over-quarter to $699M.

Based on Pier Capital's 13F filing for Q4 2023, filed 15 Feb 2024.